Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANGION BIOMEDICA CORP.

(ANGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Stifel Adjusts Price Target on Angion Biomedica to $15 from $40, Keeps Buy Rating

10/27/2021 | 11:39am EST


ę MT Newswires 2021
All news about ANGION BIOMEDICA CORP.
01/05ANGION BIOMEDICA : Current Corporate Presentation
PU
01/05ANGION BIOMEDICA : Results of Operations and Financial Condition - Form 8-K
PU
01/04ANGION BIOMEDICA CORP. : Results of Operations and Financial Condition, Costs Associated w..
AQ
01/04Angion Provides Corporate Update and Announces Participation in Upcoming Investor Confe..
AQ
01/04Angion Biomedica Corp. Provides ANG-3070 Program Update
CI
2021Health Care Stocks Holding Onto Midday Gains
MT
2021Health Care Stocks Flat To Higher Premarket Thursday
MT
2021Angion Biomedica Jumps in Pre-Market Trading After CEO Jay Venkatesan Acquires More Tha..
MT
2021Oppenheimer Adjusts Angion Biomedica PT to $8 From $15, Maintains Outperform Rating
MT
2021Health Care Stocks Mixed Premarket Friday
MT
More news
Analyst Recommendations on ANGION BIOMEDICA CORP.
More recommendations
Financials (USD)
Sales 2021 4,12 M - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 66,2 M 66,2 M -
Capi. / Sales 2021 16,1x
Capi. / Sales 2022 6,83x
Nbr of Employees 72
Free-Float 59,6%
Chart ANGION BIOMEDICA CORP.
Duration : Period :
Angion Biomedica Corp. Technical Analysis Chart | ANGN | US03476J1079 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 2,21 $
Average target price 21,00 $
Spread / Average Target 850%
Managers and Directors
Jay R. Venkatesan President, Chief Executive Officer & Director
Greg S. Curhan Chief Financial Officer
Itzhak D. Goldberg Executive Chairman & Chief Scientific Officer
John F. Neylan Chief Medical Officer & Senior Vice President
Jennifer J. Rhodes Secretary, Chief Compliance Office & Senior VP
Sector and Competitors
1st jan.Capi. (M$)
ANGION BIOMEDICA CORP.-23.79%66
MODERNA, INC.-34.04%67 921
LONZA GROUP AG-13.71%53 315
IQVIA HOLDINGS INC.-13.38%46 690
SEAGEN INC.-13.93%24 331
ICON PUBLIC LIMITED COMPANY-17.37%20 831